• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.一项长达 20 年的多随访纵向研究,评估抗精神病药物是否有助于精神分裂症患者的工作功能。
Psychiatry Res. 2017 Oct;256:267-274. doi: 10.1016/j.psychres.2017.06.069. Epub 2017 Jun 22.
2
Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study.使用抗精神病药物治疗精神分裂症能否消除或减轻精神病症状?一项为期20年的多次随访研究。
Psychol Med. 2014 Oct;44(14):3007-16. doi: 10.1017/S0033291714000610. Epub 2014 Mar 24.
3
Do all schizophrenia patients need antipsychotic treatment continuously throughout their lifetime? A 20-year longitudinal study.所有精神分裂症患者都需要终身持续接受抗精神病药物治疗吗?一项 20 年的纵向研究。
Psychol Med. 2012 Oct;42(10):2145-55. doi: 10.1017/S0033291712000220. Epub 2012 Feb 17.
4
Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications: a 15-year multifollow-up study.未服用抗精神病药物的精神分裂症患者的预后和康复相关因素:一项15年的多随访研究。
J Nerv Ment Dis. 2007 May;195(5):406-14. doi: 10.1097/01.nmd.0000253783.32338.6e.
5
[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].[精神分裂症患者护理环境的成本效益分析:长效注射制剂下非典型抗精神病药物的影响]
Encephale. 2005 Mar-Apr;31(2):235-46. doi: 10.1016/s0013-7006(05)82390-5.
6
Long-term morbidity associated with delayed treatment of first admission schizophrenic patients: a re-analysis of the Camarillo State Hospital data.首次入院精神分裂症患者延迟治疗相关的长期发病率:对卡马里洛州立医院数据的重新分析
Psychol Med. 1997 Mar;27(2):261-8. doi: 10.1017/s0033291796004345.
7
Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE study.阿立哌唑对精神分裂症患者言语记忆和流畅性的影响:来自 ESCAPE 研究的结果。
CNS Drugs. 2012 Nov;26(11):975-82. doi: 10.1007/s40263-012-0003-4.
8
Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics.非典型抗精神病药物对精神分裂症进行自然主义治疗中的抗精神病药物单一疗法与联合用药
BMC Psychiatry. 2005 May 27;5:26. doi: 10.1186/1471-244X-5-26.
9
Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.未治疗精神病的持续时间及其对精神分裂症症状恢复的影响——初步结果。
Neuro Endocrinol Lett. 2008 Dec;29(6):990-4.
10
Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.精神分裂症患者出院后接受口服与长效注射抗精神病药物治疗的抗精神病药依从性和再入院情况。
J Manag Care Spec Pharm. 2015 Sep;21(9):754-68. doi: 10.18553/jmcp.2015.21.9.754.

引用本文的文献

1
Schizophrenia: Genetics, neurological mechanisms, and therapeutic approaches.精神分裂症:遗传学、神经机制及治疗方法
Neural Regen Res. 2026 Mar 1;21(3):1089-1103. doi: 10.4103/NRR.NRR-D-24-01375. Epub 2025 May 6.
2
Systematic review and meta-analysis of early visual processing, social cognition, and functional outcomes in schizophrenia spectrum disorders.精神分裂症谱系障碍早期视觉处理、社会认知及功能结局的系统评价与荟萃分析
Schizophr Res Cogn. 2025 Feb 15;40:100351. doi: 10.1016/j.scog.2025.100351. eCollection 2025 Jun.
3
Effectiveness of antipsychotic medication in patients with schizophrenia in a real world retrospective observational study in Ethiopia.埃塞俄比亚一项真实世界回顾性观察研究中抗精神病药物对精神分裂症患者的疗效
Sci Rep. 2025 Feb 7;15(1):4663. doi: 10.1038/s41598-025-85832-3.
4
Multidimensional outcome of first-episode psychosis: a network analysis.首发精神病的多维结局:一项网络分析
Psychol Med. 2025 Feb 6;55:e29. doi: 10.1017/S0033291724003465.
5
The Association Between Antipsychotics and Bone Fragility: An Updated Comprehensive Review.抗精神病药物与骨脆性之间的关联:最新综合综述
Diagnostics (Basel). 2024 Dec 5;14(23):2745. doi: 10.3390/diagnostics14232745.
6
Use and discontinuation of antipsychotic medication in 20 years following a first episode of schizophrenia: results from the OPUS trial.首发精神分裂症后20年抗精神病药物的使用与停药情况:OPUS试验结果
Psychol Med. 2024 Nov 18;54(15):1-11. doi: 10.1017/S0033291724002678.
7
Deprescribing antipsychotics in patients with schizophrenia: findings from a specialized clinic.精神分裂症患者停用抗精神病药物:来自一家专科诊所的研究结果
Psychol Med. 2024 Oct 15;54(13):1-10. doi: 10.1017/S0033291724001910.
8
The pharmacological treatment of schizophrenia: How far have we come?精神分裂症的药物治疗:我们取得了多大进展?
PCN Rep. 2022 May 30;1(2):e13. doi: 10.1002/pcn5.13. eCollection 2022 Jun.
9
Identifying subgroups based on self-assessment of ability in patients with schizophrenia and its relationship with vocational outcomes.基于精神分裂症患者能力自我评估识别亚组及其与职业结局的关系。
Hong Kong J Occup Ther. 2022 Jun;35(1):35-43. doi: 10.1177/15691861221075715. Epub 2022 Feb 17.
10
Trajectories of response in schizophrenia-spectrum disorders: A one-year prospective cohort study of antipsychotic effectiveness.精神分裂症谱系障碍的反应轨迹:一项关于抗精神病药物疗效的一年期前瞻性队列研究。
World J Psychiatry. 2022 Mar 19;12(3):521-532. doi: 10.5498/wjp.v12.i3.521.

本文引用的文献

1
Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.首次发作精神病10年后抗精神病药物与精神病症状的缓解
Schizophr Res. 2017 Apr;182:42-48. doi: 10.1016/j.schres.2016.10.030. Epub 2016 Oct 27.
2
Should psychiatrists be more cautious about the long-term prophylactic use of antipsychotics?精神科医生是否应该更加谨慎地使用抗精神病药进行长期预防?
Br J Psychiatry. 2016 Nov;209(5):361-365. doi: 10.1192/bjp.bp.116.182683.
3
Symptoms, functioning and coping strategies in individuals with schizophrenia spectrum disorders who do not take antipsychotic medication: a comparative interview study.未服用抗精神病药物的精神分裂症谱系障碍患者的症状、功能及应对策略:一项对比访谈研究
Psychol Med. 2016 Jul;46(10):2179-88. doi: 10.1017/S0033291716000775. Epub 2016 Jun 7.
4
Is the Evidence Strong Enough to Warrant Long-Term Antipsychotic Use in Compulsory Outpatient Treatment?证据是否足够有力,足以证明在强制门诊治疗中使用长效抗精神病药物是合理的?
Psychiatr Serv. 2016 Jul 1;67(7):784-6. doi: 10.1176/appi.ps.201500408. Epub 2016 Mar 15.
5
Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia.多巴胺超敏性精神病是治疗抵抗性精神分裂症的关键因素。
Psychiatry Res. 2015 Jun 30;227(2-3):278-82. doi: 10.1016/j.psychres.2015.02.021. Epub 2015 Mar 31.
6
Improving the management of disruptive behavior and reducing antipsychotic medications in nursing facility residents.改善护理机构居民中破坏性行为的管理并减少抗精神病药物的使用。
Consult Pharm. 2014 Dec;29(12):797-812. doi: 10.4140/TCP.n.2014.797.
7
Does treatment of schizophrenia with antipsychotic medications eliminate or reduce psychosis? A 20-year multi-follow-up study.使用抗精神病药物治疗精神分裂症能否消除或减轻精神病症状?一项为期20年的多次随访研究。
Psychol Med. 2014 Oct;44(14):3007-16. doi: 10.1017/S0033291714000610. Epub 2014 Mar 24.
8
Is schizophrenia a dopamine supersensitivity psychotic reaction?精神分裂症是否是一种多巴胺超敏性精神病反应?
Prog Neuropsychopharmacol Biol Psychiatry. 2014 Jan 3;48:155-60. doi: 10.1016/j.pnpbp.2013.10.003. Epub 2013 Oct 12.
9
Mental health system funding of cognitive enhancement interventions for schizophrenia: summary and update of the New York Office of Mental Health expert panel and stakeholder meeting.精神卫生系统为精神分裂症认知增强干预措施提供资金:纽约心理健康办公室专家小组和利益相关者会议的总结和更新。
Psychiatr Rehabil J. 2013 Sep;36(3):133-45. doi: 10.1037/prj0000020.
10
Drug-induced supersensitivity psychosis revisited: characteristics of relapse in treatment-compliant patients.重新探讨药物所致超敏性精神病:依从性治疗患者复发的特征。
Ther Adv Psychopharmacol. 2012 Feb;2(1):13-22. doi: 10.1177/2045125311431105.

一项长达 20 年的多随访纵向研究,评估抗精神病药物是否有助于精神分裂症患者的工作功能。

A 20-Year multi-followup longitudinal study assessing whether antipsychotic medications contribute to work functioning in schizophrenia.

机构信息

Department of Psychiatry, University of Illinois College of Medicine, Chicago, USA 1601 W. Taylor (M/C 912), Chicago, IL 60612, USA.

Department of Psychiatry, University of Illinois College of Medicine, Chicago, USA 1601 W. Taylor (M/C 912), Chicago, IL 60612, USA.

出版信息

Psychiatry Res. 2017 Oct;256:267-274. doi: 10.1016/j.psychres.2017.06.069. Epub 2017 Jun 22.

DOI:10.1016/j.psychres.2017.06.069
PMID:28651219
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5661946/
Abstract

To assess the long-term effectiveness of antipsychotic medications in facilitating work functioning in patients with schizophrenia we conducted longitudinal multifollowup research on 139 initially psychotic patients. The 70 patients with schizophrenia and 69 initially psychotic mood disordered control patients were followed up 6 times over 20 years. We compared the influence on work functioning of patients with schizophrenia continuously prescribed antipsychotics with patients with schizophrenia not prescribed antipsychotics, using statistical controls for inter-subject differences. While antipsychotics reduce or eliminate flagrant psychosis for most patients with schizophrenia at acute hospitalizations, four years later and continually until the 20 year followups, patients with schizophrenia not prescribed antipsychotics had significantly better work functioning. The work performance of the patients who were continuously prescribed antipsychotics was at a low rate and did not improve over time. Multiple other factors also interfere with work functioning. The data suggest that some patients with schizophrenia not prescribed antipsychotics for prolonged periods can function relatively well. Multiple other factors are associated with poor post-hospital work performance. The longitudinal data raise questions about prolonged treatment of schizophrenia with antipsychotic medications.

摘要

为了评估抗精神病药物在促进精神分裂症患者工作功能方面的长期效果,我们对 139 名首发精神病患者进行了纵向多随访研究。70 名精神分裂症患者和 69 名首发心境障碍对照患者在 20 年内随访 6 次。我们通过统计学控制受试者间差异,比较了持续服用抗精神病药物的精神分裂症患者和未服用抗精神病药物的精神分裂症患者对工作功能的影响。虽然抗精神病药物在急性住院期间可以减轻或消除大多数精神分裂症患者的明显精神病症状,但 4 年后直至 20 年随访时,未服用抗精神病药物的精神分裂症患者的工作功能明显更好。持续服用抗精神病药物的患者的工作表现率较低,且随着时间的推移没有改善。其他多个因素也会干扰工作功能。这些数据表明,一些未经抗精神病药物长期治疗的精神分裂症患者可以相对较好地发挥功能。其他多个因素与住院后工作表现不佳有关。纵向数据引发了关于抗精神病药物长期治疗精神分裂症的问题。